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Background:  Although reduced heart rate variability (HRV) is associated with various cardiovascular conditions, its significance in younger 
populations without clinically evident cardiovascular disease (CVD) is unknown. We sought to study the association between HRV and markers of 
subclinical CVD in younger and middle-aged adults.
Method: The relationships between parameters of HRV and 3 separate markers of subclinical CVD (CAC: coronary artery calcium; IMT: common 
carotid artery intima-media thickness; and LVMI: ECG-determined left ventricular mass index) were examined using logistic regression analysis for 
the categorical outcome variable and multiple linear regression analysis for continuous outcome variables.
Results:  In 1955 participants of CARDIA year-20 examination (mean age 45.3 ± 3.5; 828 males; 1150 whites; no prior history of CVD) we found 
no association between HRV and presence of CAC. There were inverse relationships between HRV and most of the outcome measures but these were 
attenuated to non-significance after adjustment for various demographic and clinical characteristics (see table).
Conclusion:  Reduced HRV was not associated with subclinical CVD in asymptomatic young and middle-aged adults after adjustment for other risk 
factors; hence, other mechanisms may explain its adverse prognosis. Longitudinal studies are needed to evaluate the long-term impact of autonomic 
dysregulation on the development of CVD in younger and middle-aged adults.
